Malekan Mohammadali, Tabaraie Bahman, Akhoundtabar Ladan, Afrough Parviz, Behrouzi Ava
Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Kousha Faravar Giti, Industrial Research Institute of Biotechnology, Tehran, Iran.
Avicenna J Med Biotechnol. 2017 Jul-Sep;9(3):138-141.
is a multiple-antibiotic-resistant opportunistic pathogen that is being isolated with increasing frequency from patients with health-care-associated infections. is inherently resistant to most of the available antimicrobial agents. Spread of resistant strains has been attributed, in part, to class I integrons. susceptibility studies have shown trimethoprim-sulfamethoxazole and new floroquinolones as two important agents with activity against these organisms.
150 isolates of were isolated from clinical samples such as respiratory discharges, sputum, and catheter and hospital environments. These isolates were also subjected to susceptibility testing and polymerase chain reaction for four groups of genes including encoding integron elements, and encoding trimethoprim-sulfamethoxazole resistance and encoding quinolone resistance.
The rate of resistance to trimethoprim-sulfamethoxazole was up to 27 (18%) and the highest resistance to quinolone family belonged to ofloxacin (20%) and the lowest rate was for gatifloxacin (16%). The results showed that 14% of isolates contained integron elements concomitantly with and genes.
Resistance rate of to co-trimoxazole and fluoroquinolones and detection of integron elements between isolates in this study showed that this rate corresponded to other data obtained from other studies.
[病原体名称]是一种多重耐药的机会致病菌,从医疗保健相关感染患者中分离出的频率越来越高。它对大多数现有的抗菌药物具有固有抗性。耐药菌株的传播部分归因于I类整合子。药敏研究表明,甲氧苄啶 - 磺胺甲恶唑和新型氟喹诺酮类是对这些微生物具有活性的两种重要药物。
从呼吸道分泌物、痰液、导管及医院环境等临床样本中分离出150株[病原体名称]菌株。这些菌株还接受了药敏试验以及针对四组基因的聚合酶链反应检测,这四组基因包括编码整合子元件的基因、编码对甲氧苄啶 - 磺胺甲恶唑耐药的基因以及编码对喹诺酮耐药的基因。
对甲氧苄啶 - 磺胺甲恶唑的耐药率高达27(18%),对喹诺酮类药物耐药率最高的是氧氟沙星(20%),最低的是加替沙星(16%)。结果显示,14%的分离株同时含有整合子元件以及[相关基因名称1]和[相关基因名称2]基因。
本研究中[病原体名称]对复方新诺明和氟喹诺酮类的耐药率以及分离株之间整合子元件的检测结果表明,该耐药率与其他研究获得的其他数据相符。